BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Habtemariam S. Berberine pharmacology and the gut microbiota: A hidden therapeutic link. Pharmacol Res. 2020;155:104722. [PMID: 32105754 DOI: 10.1016/j.phrs.2020.104722] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Wang M. New Insights of Anti-Hyperglycemic Agents and Traditional Chinese Medicine on Gut Microbiota in Type 2 Diabetes. Drug Des Devel Ther 2021;15:4849-63. [PMID: 34876807 DOI: 10.2147/DDDT.S334325] [Reference Citation Analysis]
2 Ardalani H, Hejazi Amiri F, Hadipanah A, Kongstad KT. Potential antidiabetic phytochemicals in plant roots: a review of in vivo studies. J Diabetes Metab Disord 2021;20:1837-54. [PMID: 34900828 DOI: 10.1007/s40200-021-00853-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yang L, Yu S, Yang Y, Wu H, Zhang X, Lei Y, Lei Z. Berberine improves liver injury induced glucose and lipid metabolic disorders via alleviating ER stress of hepatocytes and modulating gut microbiota in mice. Bioorg Med Chem 2021;55:116598. [PMID: 34979291 DOI: 10.1016/j.bmc.2021.116598] [Reference Citation Analysis]
4 Li DD, Yu P, Xiao W, Wang ZZ, Zhao LG. Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs. Curr Top Med Chem 2020;20:2634-47. [PMID: 32901585 DOI: 10.2174/1568026620666200908165913] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
5 Alibi S, Crespo D, Navas J. Plant-Derivatives Small Molecules with Antibacterial Activity. Antibiotics (Basel) 2021;10:231. [PMID: 33668943 DOI: 10.3390/antibiotics10030231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Šudomová M, Berchová-Bímová K, Marzocco S, Liskova A, Kubatka P, Hassan STS. Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers. Viruses 2021;13:1014. [PMID: 34071559 DOI: 10.3390/v13061014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hu R, Yuan Y, Liu C, Zhou J, Ji L, Jiang G. New insights into the links between anti-diabetes drugs and gut microbiota. Endocr Connect 2021;10:R36-42. [PMID: 33338029 DOI: 10.1530/EC-20-0431] [Reference Citation Analysis]
8 Hashemzaei M, Rezaee R. A review on pain‐relieving activity of berberine. Phytotherapy Research 2021;35:2846-53. [DOI: 10.1002/ptr.6984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Dong C, Yu J, Yang Y, Zhang F, Su W, Fan Q, Wu C, Wu S. Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion. Biomed Pharmacother 2021;139:111595. [PMID: 33862492 DOI: 10.1016/j.biopha.2021.111595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Homayoonfal M, Asemi Z, Yousefi B. Targeting long non coding RNA by natural products: Implications for cancer therapy. Crit Rev Food Sci Nutr 2021;:1-29. [PMID: 34783279 DOI: 10.1080/10408398.2021.2001785] [Reference Citation Analysis]
11 Xia F, Wen LP, Ge BC, Li YX, Li FP, Zhou BJ. Gut microbiota as a target for prevention and treatment of type 2 diabetes: Mechanisms and dietary natural products. World J Diabetes 2021; 12(8): 1146-1163 [PMID: 34512884 DOI: 10.4239/wjd.v12.i8.1146] [Reference Citation Analysis]
12 Zhu C, Huang K, Bai Y, Feng X, Gong L, Wei C, Huang H, Zhang H. Dietary supplementation with berberine improves growth performance and modulates the composition and function of cecal microbiota in yellow-feathered broilers. Poult Sci 2021;100:1034-48. [PMID: 33518062 DOI: 10.1016/j.psj.2020.10.071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Gu L, Ke Y, Gan J, Li X. Berberine suppresses bone loss and inflammation in ligature-induced periodontitis through promotion of the G protein-coupled estrogen receptor-mediated inactivation of the p38MAPK/NF-κB pathway. Arch Oral Biol 2021;122:104992. [PMID: 33338754 DOI: 10.1016/j.archoralbio.2020.104992] [Reference Citation Analysis]
14 Moszak M, Szulińska M, Walczak-Gałęzewska M, Bogdański P. Nutritional Approach Targeting Gut Microbiota in NAFLD-To Date. Int J Environ Res Public Health 2021;18:1616. [PMID: 33567710 DOI: 10.3390/ijerph18041616] [Reference Citation Analysis]
15 Cafferata EA, Castro-Saavedra S, Fuentes-Barros G, Melgar-Rodríguez S, Rivera F, Carvajal P, Hernández M, Cortés BI, Cortez C, Cassels BK, Vernal R. Boldine inhibits the alveolar bone resorption during ligature-induced periodontitis by modulating the Th17/Treg imbalance. J Periodontol 2021;92:123-36. [PMID: 32490537 DOI: 10.1002/JPER.20-0055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Xu T, Ge Y, Du H, Li Q, Xu X, Yi H, Wu X, Kuang T, Fan G, Zhang Y. Berberis kansuensis extract alleviates type 2 diabetes in rats by regulating gut microbiota composition. J Ethnopharmacol 2021;273:113995. [PMID: 33675912 DOI: 10.1016/j.jep.2021.113995] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Zhang X, Yang Y, Zhang F, Yu J, Sun W, Wang R, Wu C. Traditional Chinese medicines differentially modulate the gut microbiota based on their nature (Yao-Xing). Phytomedicine 2021;85:153496. [PMID: 33714730 DOI: 10.1016/j.phymed.2021.153496] [Reference Citation Analysis]
18 Wang T, Liu J, Luo X, Hu L, Lu H. Functional metabolomics innovates therapeutic discovery of traditional Chinese medicine derived functional compounds. Pharmacol Ther 2021;224:107824. [PMID: 33667524 DOI: 10.1016/j.pharmthera.2021.107824] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Fang Y, Zhang J, Zhu S, He M, Ma S, Jia Q, Sun Q, Song L, Wang Y, Duan L. Berberine ameliorates ovariectomy-induced anxiety-like behaviors by enrichment in equol generating gut microbiota. Pharmacol Res 2021;165:105439. [PMID: 33493658 DOI: 10.1016/j.phrs.2021.105439] [Reference Citation Analysis]
20 Xu C, Wang F, Huang F, Yang M, He D, Deng L. Targeting effect of berberine on type I fimbriae of Salmonella Typhimurium and its effective inhibition of biofilm. Appl Microbiol Biotechnol 2021;105:1563-73. [PMID: 33496815 DOI: 10.1007/s00253-021-11116-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Singh S, Pathak N, Fatima E, Negi AS. Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine. Eur J Med Chem 2021;226:113839. [PMID: 34536668 DOI: 10.1016/j.ejmech.2021.113839] [Reference Citation Analysis]
22 Han R, Qiu H, Zhong J, Zheng N, Li B, Hong Y, Ma J, Wu G, Chen L, Sheng L, Li H. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota. Phytomedicine 2021;85:153544. [PMID: 33773192 DOI: 10.1016/j.phymed.2021.153544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Lyu Y, Lin L, Xie Y, Li D, Xiao M, Zhang Y, Cheung SCK, Shaw PC, Yang X, Chan PKS, Kong APS, Zuo Z. Blood-Glucose-Lowering Effect of Coptidis Rhizoma Extracts From Different Origins via Gut Microbiota Modulation in db/db Mice. Front Pharmacol 2021;12:684358. [PMID: 34211397 DOI: 10.3389/fphar.2021.684358] [Reference Citation Analysis]
24 Wang Y, Tai YL, Zhao D, Zhang Y, Yan J, Kakiyama G, Wang X, Gurley EC, Liu J, Liu J, Liu J, Lai G, Hylemon PB, Pandak WM, Chen W, Zhou H. Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways. Cells 2021;10:210. [PMID: 33494295 DOI: 10.3390/cells10020210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
25 Yang S, Li D, Yu Z, Li Y, Wu M. Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota. Front Pharmacol 2021;12:709629. [PMID: 34305616 DOI: 10.3389/fphar.2021.709629] [Reference Citation Analysis]
26 Habtemariam S. The Quest to Enhance the Efficacy of Berberine for Type-2 Diabetes and Associated Diseases: Physicochemical Modification Approaches. Biomedicines 2020;8:E90. [PMID: 32325761 DOI: 10.3390/biomedicines8040090] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Kong M, Xie K, Lv M, Li J, Yao J, Yan K, Wu X, Xu Y, Ye D. Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: Lessons learned and future promise. Biomed Pharmacother 2021;133:110975. [PMID: 33212375 DOI: 10.1016/j.biopha.2020.110975] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
28 Konrath EL, Arbo MD, Arbo BD, Hort MA, Elisabetsky E, Leal MB. Plants with Anti-Addictive Potential. Adv Exp Med Biol 2021;1308:185-215. [PMID: 33861445 DOI: 10.1007/978-3-030-64872-5_14] [Reference Citation Analysis]
29 Wu F, Shao Q, Xia Q, Hu M, Zhao Y, Wang D, Fang K, Xu L, Zou X, Chen Z, Chen G, Lu F. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway. Phytomedicine 2021;83:153487. [PMID: 33636476 DOI: 10.1016/j.phymed.2021.153487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
30 Ming J, Yu X, Xu X, Wang L, Ding C, Wang Z, Xie X, Li S, Yang W, Luo S, He Q, Du Y, Tian Z, Gao X, Ma K, Fang Y, Li C, Zhao J, Wang X, Ji Q. Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study. Genome Med 2021;13:125. [PMID: 34365978 DOI: 10.1186/s13073-021-00942-7] [Reference Citation Analysis]
31 Huang DN, Wu FF, Zhang AH, Sun H, Wang XJ. Efficacy of berberine in treatment of rheumatoid arthritis: From multiple targets to therapeutic potential. Pharmacol Res 2021;169:105667. [PMID: 33989762 DOI: 10.1016/j.phrs.2021.105667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Pang H, Zhou Y, Wang J, Wu H, Liu X, Gao F, Xiao Z. Berberine Influences the Survival of Fat Grafting by Inhibiting Autophagy and Apoptosis of Human Adipose Derived Mesenchymal Stem Cells. Drug Des Devel Ther 2021;15:4795-809. [PMID: 34876804 DOI: 10.2147/DDDT.S337215] [Reference Citation Analysis]
33 Han Y, Xiang Y, Shi Y, Tang X, Pan L, Gao J, Bi R, Lai X. Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment. Evid Based Complement Alternat Med 2021;2021:9987097. [PMID: 34471420 DOI: 10.1155/2021/9987097] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]